Serina Therapeutics, Inc.
SER- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708599
In the last 90 days, Serina Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.73M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Serina Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 32 | 38 | +6 |
| Shares | 4.75M | 4.85M | +103.0K (+2.2%) |
| Value | $4.46M | $5.28M | +$822.1K (+18.4%) |
New holders (9)
Institutions that held Serina Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 33,314 | $36.0K | 0.00% |
| Jane Street Group, LLC | 28,116 | $31.0K | 0.00% |
| Susquehanna International Group, LLP | 26,522 | $29.0K | 0.00% |
| Millennium Management LLC | 13,115 | $14.0K | 0.00% |
| FMR LLC | 15 | $0 | 0.00% |
| Chilton Capital Management LLC | 40 | $0 | 0.00% |
| CWM, LLC | 200 | $0 | 0.00% |
| Lindbrook Capital, LLC | 172 | $0 | 0.00% |
| CoreCap Advisors, LLC | 10 | – | – |
Sold out (3)
Institutions that held Serina Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Citadel Advisors LLC | 40,537 | $38.0K |
| Meeder Asset Management Inc | 121 | $0 |
| Community Bank, N.A. | 50 | $0 |